<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://newdrugapprovals.org/2026/11/22/venglustat-ibiglustat/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T03:03:44+00:00</news:publication_date><news:title>Venglustat, Ibiglustat</news:title><news:keywords>FDA 2026, APPROVALS 2026, anax labs, Venglustat malate, Genz-682452, Genz-682452-AA, WHO 10063, SAR-402671, GZ402671, Infilbray, venglustat, Ibiglustat L-malate, BLP1XA3FZA, SAR 402671, GZ/SAR402671</news:keywords></news:news></url><url><loc>https://newdrugapprovals.org/2026/11/21/adrabetadex/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T02:36:07+00:00</news:publication_date><news:title>Adrabetadex</news:title><news:keywords>FDA 2026, APPROVALS 2026, anax labs, 8W6Q67R6NX, adrabetadex, Lembaz, VT-270, VTS-270, Niemann–Pick disease type C, KLEPTOSE HPB, VTS270</news:keywords></news:news></url></urlset>
